HYAL1 and breast carcinoma: On the other hand, DDIT significantly reduced the expression of hyaluronidases HYAL-2, TMEM2 (encoding the main hyaluronidase expressed in this breast cancer cell line) and KIAA1199/CEMIP, while it enhanced HYAL-1 expression.